RFK 将停止对哪些疫苗的推荐?
$1,399,277 交易量
Dec 31, 2025
脊髓灰质炎
$22,600 交易量
否
脊髓灰质炎
$22,600 交易量
否
COVID-19
$602,048 交易量
否
COVID-19
$602,048 交易量
否
人乳头瘤病毒
$316,492 交易量
否
人乳头瘤病毒
$316,492 交易量
否
流感
$28,349 交易量
否
流感
$28,349 交易量
否
乙型肝炎
$166,216 交易量
否
乙型肝炎
$166,216 交易量
否
麻疹、腮腺炎和风疹
$263,573 交易量
否
麻疹、腮腺炎和风疹
$263,573 交易量
否
规则
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
创建于: Feb 21, 2025, 7:10 PM ET
交易量
$1,399,277结束日期
Dec 31, 2025创建于
Feb 21, 2025, 7:10 PM ETResolver
0x6A9D22261...已提议结果: 否
无争议
最终结果: 否
RFK 将停止对哪些疫苗的推荐?
$1,399,277 交易量
脊髓灰质炎
$22,600 交易量
否
COVID-19
$602,048 交易量
否
人乳头瘤病毒
$316,492 交易量
否
流感
$28,349 交易量
否
乙型肝炎
$166,216 交易量
否
麻疹、腮腺炎和风疹
$263,573 交易量
否
关于
交易量
$1,399,277结束日期
Dec 31, 2025创建于
Feb 21, 2025, 7:10 PM ETResolver
0x6A9D22261...注意外部链接。
注意外部链接。

注意外部链接。
注意外部链接。